|
TMEM163 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
6.176900E-03 |
| Normal-vs-Stage3 |
1.33819955117076E-10 |
| Normal-vs-Stage4 |
2.61130000001053E-06 |
| Stage1-vs-Stage2 |
7.396200E-01 |
| Stage1-vs-Stage3 |
1.665040E-01 |
| Stage1-vs-Stage4 |
8.241400E-01 |
| Stage2-vs-Stage3 |
7.750600E-01 |
| Stage2-vs-Stage4 |
8.729200E-01 |
| Stage3-vs-Stage4 |
4.637800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.74940999999595E-05 |
| Normal-vs-Asian |
7.6905000000016E-05 |
| Caucasian-vs-AfricanAmerican |
5.76750003311588E-09 |
| Caucasian-vs-Asian |
1.362360E-01 |
| AfricanAmerican-vs-Asian |
4.380300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60229615633989E-11 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.412600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(41-60Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(61-80Yrs) |
1.58755999999372E-05 |
| Normal-vs-Age(81-100Yrs) |
1.700130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.160000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.581500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.177600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.604200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.493760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.776600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.704800E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
6.375000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
3.97659999999966E-05 |
| Tall-VS-Other |
5.614600E-01 |
| Tall-VS-Normal |
2.10899999997238E-06 |
| Follicular-VS-Other |
2.210600E-01 |
| Follicular-VS-Normal |
2.178200E-04 |
| Other-VS-Normal |
1.890960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62747593179802E-12 |
| Normal-vs-N1 |
3.87690000003271E-06 |
| N0-vs-N1 |
2.068600E-01 |
|
|
